As the main synthetase of PGD2, PTGDS had also been shown to be downregulated in multiple tumours, such as lung cancer 38, gastric cancer 39, prostate cancer 40, and cervical cancer 41. This evidence concerns the gene PTGDS and prostate carcinoma.